Shockwave therapy is effective for several musculoskeletal conditions, with the strongest evidence supporting its use for plantar fasciitis, calcific shoulder tendinitis, and certain chronic tendon problems. Success rates vary by condition and the type of shockwave energy used, but most studies show meaningful pain reduction in 50% to 75% of patients. It’s not a magic fix for every injury, though, and results depend heavily on the condition being treated, the energy level applied, and the treatment protocol.
How Shockwave Therapy Works
Shockwave therapy delivers pulses of acoustic energy into damaged tissue. These pressure waves create a mechanical stimulus that triggers a cascade of biological responses at the cellular level, a process called mechanotransduction. Essentially, the physical force of the shockwaves gets converted into chemical signals that promote healing.
The most important of these responses is the growth of new blood vessels. Shockwaves stimulate new blood vessel formation within about a week of treatment, and this effect persists for at least 12 weeks afterward. More blood flow means more oxygen and nutrients reaching damaged tissue. At the same time, the therapy triggers the release of growth factors that help repair tendons, bones, and soft tissue. In animal studies, shockwave treatment increased the production of key proteins involved in tissue regeneration and cell proliferation at the tendon-bone junction.
This is why shockwave therapy tends to work best for chronic conditions where healing has stalled. It essentially restarts the body’s repair process in tissue that has stopped healing on its own.
Results for Plantar Fasciitis
Plantar fasciitis is the most commonly treated condition and has the largest body of research. The results split clearly based on the intensity of energy used. In a meta-analysis of randomized controlled trials, high-intensity shockwave therapy produced a success rate of 66.2% (defined as at least a 50% reduction in pain). Low-intensity treatment performed significantly worse, with only 42% of patients responding.
How does that compare to steroid injections, the most common alternative? At the three-month mark, both treatments are effective at reducing pain and improving function. Functional scores were essentially identical between the two groups across multiple scoring systems. The critical difference is what happens later. A Cochrane review found that the pain relief from corticosteroid injections does not hold beyond six months, while shockwave therapy’s effects are driven by actual tissue repair rather than temporary inflammation suppression. For people dealing with chronic heel pain that keeps coming back after injections, shockwave therapy offers a fundamentally different approach.
Results for Shoulder Calcific Tendinitis
Shockwave therapy shows some of its most dramatic results in calcific tendinitis of the shoulder, where calcium deposits build up in the rotator cuff tendons and cause significant pain and stiffness. Success rates for this condition range from 30% to 85% depending on the study, but the numbers from well-designed trials are encouraging.
In one study, 75% of patients experienced at least a 30% improvement in shoulder function scores along with decreased pain at three months. Another trial found that 72% of patients with shoulder calcific tendinitis noticed symptom improvement after a single session. The trajectory of improvement is particularly striking. In one controlled study, shoulder function scores nearly doubled within two weeks of treatment (from 38.3 to 56.0 on a standardized scale), continued climbing at six weeks (72.8), and reached 87.7 by 12 weeks. The treatment group showed significantly greater pain reduction than controls at every time point measured.
Results for Chronic Wounds
A less well-known application is in chronic wound healing, particularly diabetic foot ulcers. In a randomized controlled trial, 54% of shockwave-treated ulcers had completely healed by the 20-week follow-up, compared to 28.5% in the control group. Average healing time was about 65 days in the treatment group versus 81 days with standard wound care alone, a difference of more than two weeks. Researchers noted significant reductions in wound size with no adverse reactions from the treatment.
What a Typical Treatment Course Looks Like
A standard course involves three to five sessions spaced about one week apart. Each session typically lasts 15 to 30 minutes. The therapy comes in two forms: focused shockwave therapy, which targets a precise area with higher energy, and radial shockwave therapy, which spreads energy over a broader zone. Focused therapy is generally more expensive and is used for deeper or more specific injuries.
Energy levels are categorized as low, medium, or high, and the choice matters. As the plantar fasciitis data shows, higher energy treatments tend to produce better outcomes for certain conditions, though they also cause more discomfort during the session. Most patients feel noticeable pressure or pain during treatment, especially at higher energy levels. This is considered a normal side effect rather than a complication.
Side Effects and Safety
Shockwave therapy has a strong safety profile. The most common side effects are temporary pain during the procedure, skin redness, and minor bruising at the treatment site. At higher energy levels or with firm contact pressure, small pinpoint-sized areas of bleeding can appear in the skin. Some patients feel lightheaded during or immediately after treatment due to a nervous system response to the discomfort.
Serious complications are rare. The few absolute contraindications include severe blood clotting disorders (for high-energy treatments), pregnancy when the shockwaves would be directed near the fetus, and active severe infections in the treatment area. Practitioners also need to ensure the lungs are not in the path of the shockwaves, as this could cause tears, bleeding, or a collapsed lung. Deeper skin injuries have been reported but are uncommon.
Cost and Insurance Coverage
Cost varies widely based on your location, the type of shockwave used, the condition being treated, and the provider’s experience. Focused shockwave therapy is generally more expensive than radial therapy. The biggest financial consideration is that most insurance companies classify shockwave therapy as experimental, which means you’ll likely pay out of pocket. Medicare and Medicaid typically do not cover it. Some commercial plans may cover the treatment for specific conditions, but coverage is inconsistent, and even plans that offer partial coverage may leave you responsible for a significant portion of the cost.
Given that a full course runs three to five sessions, the total cost can add up quickly. It’s worth checking with your insurance provider about your specific condition before committing, since coverage decisions often hinge on the diagnosis and whether the provider meets certain qualifications.
Where the Evidence Is Strongest and Weakest
The conditions with the most robust evidence behind shockwave therapy are plantar fasciitis, calcific shoulder tendinitis, and lateral epicondylitis (tennis elbow). For these, multiple randomized controlled trials and meta-analyses consistently show benefit over placebo. Chronic wound healing is a growing area with promising early results. The evidence is weaker or more mixed for conditions like patellar tendinopathy, Achilles tendinopathy, and non-calcific shoulder pain, where study results are less consistent and often involve smaller sample sizes.
The therapy works best when it’s matched to the right condition at the right intensity. A high-energy focused treatment for calcific tendinitis, for example, is backed by solid evidence. The same technology applied to a vague soft tissue complaint with unclear diagnosis is much less likely to deliver results. If a provider recommends shockwave therapy, the specific condition and the protocol they plan to use matter as much as the technology itself.